Everolimus-based immunosuppression in heart transplantation reduces cardiac allograft vasculopathy progression and preserves renal function: a systematic review and meta-analysis

30 August 2026 (17:15 - 18:05)
Organised by: Logo
Congress Presentation Part of: Heart transplantation: rationale for antiplatelet therapy post coronary artery bypass grafting surgery Transplantation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology